Akari Therapeutics Issues 2025 End of Year Letter to Shareholders
December 30, 2025 09:15 ET Â | Source: Akari Therapeutics Plc TAMPA, Fla.…
Genenta Reports Long-Term Survival Trends and Immune Findings in Brain Tumor (GBM) Trial
Company Announces Approximately $30 Million in Cash and Short-Term Investments Following Its…